Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of an investigational blood thinner,
apixaban, in preventing venous thromboembolic (VTE) recurrence or death in patients with deep
vein thrombosis (DVT) or pulmonary embolism (PE)